|
HS Code |
496562 |
| Chemical Name | 2-Amino-7-Bromoquinoxaline |
| Cas Number | 16706-64-0 |
| Molecular Formula | C8H6BrN3 |
| Molecular Weight | 224.06 g/mol |
| Appearance | Light yellow to beige powder |
| Melting Point | 259-262°C |
| Solubility | Slightly soluble in DMSO, ethanol, and methanol |
| Purity | Typically ≥98% (varies by supplier) |
| Synonyms | 7-Bromoquinoxalin-2-amine |
| Smiles | C1=CC2=NC(=NC=C2C(=C1)Br)N |
| Inchi | InChI=1S/C8H6BrN3/c9-5-1-2-6-7(3-5)12-8(10)11-6/h1-3H,(H2,10,11,12) |
As an accredited 2-Amino-7-Bromoquinoxaline factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 2-Amino-7-Bromoquinoxaline prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Chemistry often surprises us with simple molecules that push the boundaries of research and innovation. When I first encountered 2-Amino-7-Bromoquinoxaline in my work, I remember being struck by the punch packed into such a compact structure. This compound, built on the quinoxaline backbone with an amino group at the 2-position and a bromine sitting at the 7-position, finds its way into laboratories hungry for precision and reliability. In the flood of off-the-shelf quinoxalines, this one stands out not because it looks odd, but because it delivers a set of properties that matter when it counts.
Talking about specifications, what immediately grabs your attention is the combination of an amino group capable of acting as both a nucleophile and a hydrogen-bond donor, and a bromo-substituent ready for cross-coupling or halogen exchange. This specific arrangement sets the stage for targeted derivatization. The compound comes as a crystalline solid, typically pale yellow or off-white. Its melting point seems to hover impressively above room temperature, offering straightforward handling in most standard lab environments. Solubility has always struck me as respectable—enough to work with common organic solvents but not so soluble that it’s lost or wasted in downstream procedures. When you’re bench-deep in multi-step syntheses or drug scaffold development, those details can mean the difference between a good day and cleaning up a mess.
The real magic with 2-Amino-7-Bromoquinoxaline appears during synthetic explorations. My own experience with this compound started during a project concerned with kinase inhibition. Its framework mimics a range of bioactive molecules—especially when probing for ATP-binding site blockers. In medicinal chemistry, researchers constantly search for stable, tunable building blocks to speed up candidate generation and SAR (structure-activity relationship) studies. Inserting this molecule into combinatorial libraries gave me dependable yields and broad substrate flex, a rare pairing when deadlines get tight. Even outside pharma, the compound's versatility makes it useful in materials science research, where electron-rich aromatic scaffolds can seed new dye or sensor prototypes.
The combination of the amino and bromo sites creates opportunities for chemoselective transformations. Peering at competitors—plain quinoxalines, or those with only amino or bromo substituents—the contrast feels night and day. Mono-substituted analogues often force extra steps in synthesis, adding time and unnecessary cost. With both a handle for nucleophilic aromatic substitution and a reactive site for palladium-catalyzed cross coupling, 2-Amino-7-Bromoquinoxaline lands right in the sweet spot. Time saved stacking reactions on a scaffold that’s “ready for action” adds up quickly across a year’s work. In my own group, switching to this compound over other, less decorated quinoxalines cut project delays notoriously linked to challenging intermediate preparations.
Competitors in the quinoxaline world often compete on purity, cost per gram, or so-called “ease of modification.” From hands-on experience, most alternatives fall short where selective chemistry meets large-scale quantities. 2-Amino-7-Bromoquinoxaline’s two-point substitution pattern invites diverse transformations without the unpredictability you’ll run into with more heavily substituted quinoxalines (which often clog up with unwanted side products). For those who rely on clean chromatography, this means more reliable separation and less time spent trouble-shooting purification. I’ve seen plenty of graduate students breathe a sigh of relief for that reason alone—a factor rarely captured in catalog copy but obvious to anyone at the bench.
Whereas common 2,3- or 6,7-disubstituted quinoxalines often introduce steric hindrance or solubility headaches, the amino and bromo pattern here rarely leads to unmanageable clumping or slow dissolving. Even simple differences like these end up mattering, particularly under the constraints of tight research grants. What you find with this molecule is that it offers reliable entry to custom modifications—neither too reactive nor stubbornly inert. Some analogues with just the amino group lack a convenient cross-coupling partner, while bromo-only versions struggle to engage in bioactive compound development. This balance struck me as uncommon, and it’s exactly what you want for iterative design.
In my daily work, quality and reproducibility shape everything from experimental progress to how soon a team hits its next milestone. Any seasoned chemist can tell you how a supplier swap or subtle shift in raw materials throws off experiments in ways you don’t see coming. High-quality forms of 2-Amino-7-Bromoquinoxaline make life easier. Their batch-to-batch consistency, purity profiles, and ease of handling mean less downtime tracing mysterious blots on TLC plates or debugging a reaction that fizzled out overnight. I’ve watched more than one collaboration slow to a crawl when someone overlooked the difference between a poor and a premium source.
Documentation matters too. Even solid suppliers sometimes skimp on thorough spectral data or HPLC traces. I always recommend picking sources with the confidence to post those up front—seeing a crisp NMR spectrum or a single, sharp LC peak still beats a thousand words of bland reassurance about “highest standards.” It lets working scientists quickly judge what they’re really getting. Trust gets built not only through consistent product but also through transparency. Suppliers who understand this mindset end up with loyal customers, year after year.
Many in my circle have started paying greater attention to questions about sustainability and safety. 2-Amino-7-Bromoquinoxaline hasn’t typically drawn attention for hazards over and above typical aromatic amines and halides. This fact offers a small but valuable bit of peace of mind in everyday practice. Fewer worries about acute handling risks or stubborn environmental residues mean teams can focus more energy on the core work of discovery or analysis. Alongside good ventilation and standard chemical hygiene, this helps drive a safer, smoother workflow. Rapid waste stream analysis and streamlined cleanup translate into lower overhead and reduced burnout, elements that matter both in big labs and small operations.
A focus on quality also plays into greener chemistry. Consistent, high-purity input materials bring down the rate of failed runs and minimize the accumulation of contaminated waste. My own move away from cheaper, less-pure analogues followed after a string of unproductive late nights, full of repeated extractions and column runs that could have been avoided. Less waste means fewer headaches for downstream chemical management, and cuts into costs that creep up out of view.
Drawing on years spent at the bench, a handful of best practices come to mind. Simple as it may sound, working with 2-Amino-7-Bromoquinoxaline often improves with routine care—free from moisture and strong acids, stored in tight, light-proof containers. Weighing out small lots rather than exposing bulk to the atmosphere helps retain material quality. Those minor daily habits keep tedious degradation problems at bay and leave more time for the interesting work. While it feels tempting sometimes to take shortcuts during solvent selection, sticking to recommended choices—typically moderate polarity organic solvents—pays back when it’s time to separate products or recover unused material.
One detail I learned through trial and error: patience in dissolving this material reaps rewards. Gentle warming, steady stirring, and incremental solvent addition usually produce better solutions than aggressive heating. Patience also applies during workup. Filtration after reactions involving this compound tends to go smoothly, provided you’re careful about cooling rates and avoid unnecessary agitation that might trigger premature precipitation. Following these small adjustments can make the difference between a straightforward afternoon and a setback to repeat tomorrow.
Today’s research landscape demands agility—in both thinking and execution. Projects run on slim budgets, timelines shrink, and expectations rise. 2-Amino-7-Bromoquinoxaline appeals so strongly because it supports iterative, creative approaches. I remember a medicinal chemist whose frustration with inflexible synthons threatened to stall their lead optimization cycle. Moving to a combination like this allowed them to explore both arylation and amide formation in a single development run, capturing more chemical space than they anticipated. For every group with limited resources, options like these give crucial leeway to keep deadlines—and careers—moving forward.
Medicinal fields aren’t the only settings to appreciate this flexibility. Colleagues working on optoelectronic materials told me how this compound’s framework lent itself to modifications that fine-tune band gaps or electronic transitions, bringing down the number of failed experiments (and wasted starting materials) over repeated cycles. There’s something deeply satisfying about knowing that a few grams of a well-designed intermediate can support months of progress across several projects.
While some worry about the sticker price of high-value reagents, my experience tells a different story. Settling for bargain substitutes rarely saves money in the long run once you add up wasted time, failed reactions, or extra purification work. 2-Amino-7-Bromoquinoxaline costs more per gram than some generic scaffolds, but my ledger scores it as a win every time in longer projects. A little upfront investment usually brings down the hidden cost buried in labor, repeat purchases, and machine-time. I’ve made those mistakes myself, and can say from hard-won experience: buy quality at the outset and focus on the work that matters, not endless troubleshooting.
For institutions and labs with purchasing controls, one way to stretch budgets is to pool orders or coordinate among multiple research groups. Buying jointly can unlock better rates and steadier supply chains. Bigger institutions already do this; smaller outfits benefit most when teams communicate and consolidate needs. There are also growing online communities devoted to reagent sharing and responsible disposal, reducing waste and avoiding overstock. This sense of practical community makes chemistry a little less solitary, especially for early-career scientists or smaller teaching labs.
Teaching the next wave of scientists means never losing sight of the connection between supply selection and strong experimental outcomes. More than once, I’ve seen students take shortcuts with cheaper reagents and run into compounding issues—impure spots on TLC, sluggish reactions, tough purifications, and ambiguous NMR spectra. Early training in the true costs, both financial and practical, gives students more confidence and a stronger skill set for future research. Inviting them to interpret and compare real spectral data—from a solid batch of 2-Amino-7-Bromoquinoxaline versus a less-pure bottle—helps develop the pattern recognition they’ll need throughout their careers.
Mentorship goes beyond the technical. In my groups, talking students through thoughtful mole-to-gram scaling, waste minimization, and recordkeeping fosters habits that stick. Each reagent choice makes a difference, and students who start with quality materials see better results and pick up tricks for troubleshooting and optimization. In a world moving fast, the advantage goes to those who master good habits early. Those who understand reagent selection and storage, alongside reaction design, turn small wins into long-term success.
Labs today face bigger hurdles in sourcing and justifying the right reagents than ever before. Shipping policies, customs requirements, or institutional red tape sometimes slow down even the most well-intentioned project. In that context, reliable reagents like 2-Amino-7-Bromoquinoxaline help smooth the path. Their wide compatibility with established reaction conditions—Suzuki, Buchwald-Hartwig, and other palladium-catalyzed couplings as well as nucleophilic substitutions—eases concerns about investing in specialized or single-use tools. This broadens the playing field, letting more scientists, especially newcomers or those in resource-limited settings, reach results worth sharing with wider audiences.
Open sharing of protocols, troubleshooting tips, and spectral benchmarks helps lower barriers for the next generation. I’ve watched this happen in real time: collaborations spring up because common intermediates create a shared language among research groups. One group might crack a difficult functionalization, post their procedure and spectra, and in turn empower another team to solve a different problem downstream. Tools like 2-Amino-7-Bromoquinoxaline, shared wisely, can serve as bridges between disciplines and institutions, sparking fresh collaborations where no one expected.
Recent movements in open science have brought transparency to the fore, not just for data but for reagents as well. Accurate, accessible information about sources, batch records, and analytical data supports both reproducibility and peer review. 2-Amino-7-Bromoquinoxaline, widely adopted in academic and industrial contexts, benefits when suppliers and users alike contribute open, peer-verifiable characterization data. Few things build community trust as easily as real chromatograms, NMR assignments, and direct notes about successful (or failed) reaction conditions.
For those building protocols, the sharing of “negative results” or sub-optimal reaction stories around this compound does just as much good as reporting glowing successes. I’ve watched grant-funded projects take off when teams could quickly access troubleshooting resources based on shared experience, not just theory. The move toward open protocol repositories and collaborative databases benefits everyone, cutting down on repeated dead ends and supporting a culture of generosity and rigor.
Over time, you notice how best practices for using 2-Amino-7-Bromoquinoxaline don’t just travel down from senior to junior staff; they flow laterally across fields and peer groups. Watching scientists troubleshoot together—comparing sources, sharing storage tips, swapping reaction conditions—shows how collective wisdom builds up around reagents like this. The advice handed down isn’t always flashy, but it’s the steady sort that keeps labs running smoothly: fresh material outperforms old, patient work pays off more quickly than shortcuts, and sharing data speeds progress for everyone.
Conversations in break rooms, e-mail threads, or online forums have steered more successful projects than any catalog ever could. I’ve often found that honest notes in a communal lab notebook—“don’t overheat past 80°C,” “diethyl ether cleans up best after Suzuki coupling,” “LC showed trace baseline only with supplier X”—quickly save the next user hours of tinkering. These passed-along details, hard-won after real setbacks, shape a more robust research culture and make every bottle of 2-Amino-7-Bromoquinoxaline go a little further.
As new reaction types and greener protocols develop, I expect 2-Amino-7-Bromoquinoxaline will play an even greater role in fast-moving synthetic workflows. Upcoming advances in cross-coupling, continuous flow chemistry, and heterocycle functionalization depend on sturdy, versatile intermediates as their foundation. This compound’s unique reactivity profile continues to support not just routine projects but ambitious, high-risk efforts in drug design and advanced materials.
Better digital tracking, stronger supplier transparency, and community-driven troubleshooting mean even small labs can access the benefits once limited to the best-funded teams. Looking ahead, broadening access to well-characterized, reliable compounds levels the playing field and lets good science happen in more places. That’s what matters most to me: using experience and insight to give the next projects—and the people behind them—the best shot at success.